These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 33600562)
1. Generation of APOE knock-down SK-N-SH human neuroblastoma cells using CRISPR/Cas9: a novel cellular model relevant to Alzheimer's disease research. Muñoz SS; Garner B; Ooi L Biosci Rep; 2021 Feb; 41(2):. PubMed ID: 33600562 [TBL] [Abstract][Full Text] [Related]
2. The serine protease HtrA1 contributes to the formation of an extracellular 25-kDa apolipoprotein E fragment that stimulates neuritogenesis. Muñoz SS; Li H; Ruberu K; Chu Q; Saghatelian A; Ooi L; Garner B J Biol Chem; 2018 Mar; 293(11):4071-4084. PubMed ID: 29414786 [TBL] [Abstract][Full Text] [Related]
3. Cerebrospinal fluid lipoprotein delivery to human neuronal cells is increased in Alzheimer's disease and is dependent on apoE monomer concentration. Bassett CN; Swift LL; Montine KS; Markesbery WR; Montine TJ J Alzheimers Dis; 2002 Feb; 4(1):19-30. PubMed ID: 12214015 [TBL] [Abstract][Full Text] [Related]
4. Amyloid-β protein modulates the perivascular clearance of neuronal apolipoprotein E in mouse models of Alzheimer's disease. Rolyan H; Feike AC; Upadhaya AR; Waha A; Van Dooren T; Haass C; Birkenmeier G; Pietrzik CU; Van Leuven F; Thal DR J Neural Transm (Vienna); 2011 May; 118(5):699-712. PubMed ID: 21210284 [TBL] [Abstract][Full Text] [Related]
5. Ouabain-Induced Signaling and Cell Survival in SK-N-SH Neuroblastoma Cells Differentiated by Retinoic Acid. Akkuratov EE; Wu J; Sowa D; Shah ZA; Liu L CNS Neurol Disord Drug Targets; 2015; 14(10):1343-9. PubMed ID: 26295826 [TBL] [Abstract][Full Text] [Related]
7. Important differences between human and mouse APOE gene promoters: limitation of mouse APOE model in studying Alzheimer's disease. Maloney B; Ge YW; Alley GM; Lahiri DK J Neurochem; 2007 Nov; 103(3):1237-57. PubMed ID: 17854398 [TBL] [Abstract][Full Text] [Related]
9. HtrA1 Proteolysis of ApoE In Vitro Is Allele Selective. Chu Q; Diedrich JK; Vaughan JM; Donaldson CJ; Nunn MF; Lee KF; Saghatelian A J Am Chem Soc; 2016 Aug; 138(30):9473-8. PubMed ID: 27379525 [TBL] [Abstract][Full Text] [Related]
10. The allelic modulation of apolipoprotein E expression by oestrogen: potential relevance for Alzheimer's disease. Lambert JC; Coyle N; Lendon C J Med Genet; 2004 Feb; 41(2):104-12. PubMed ID: 14757857 [TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein E: diversity of cellular origins, structural and biophysical properties, and effects in Alzheimer's disease. Huang Y; Weisgraber KH; Mucke L; Mahley RW J Mol Neurosci; 2004; 23(3):189-204. PubMed ID: 15181247 [TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein E as a target for developing new therapeutics for Alzheimer's disease based on studies from protein, RNA, and regulatory region of the gene. Lahiri DK J Mol Neurosci; 2004; 23(3):225-33. PubMed ID: 15181251 [TBL] [Abstract][Full Text] [Related]
13. Microglial activation induced by factor(s) contained in sera from Alzheimer-related ApoE genotypes. Lombardi VR; García M; Cacabelos R J Neurosci Res; 1998 Nov; 54(4):539-53. PubMed ID: 9822164 [TBL] [Abstract][Full Text] [Related]
14. ApoE isoforms and carboxyl-terminal-truncated apoE4 forms affect neuronal BACE1 levels and Aβ production independently of their cholesterol efflux capacity. Dafnis I; Raftopoulou C; Mountaki C; Megalou E; Zannis VI; Chroni A Biochem J; 2018 May; 475(10):1839-1859. PubMed ID: 29743204 [TBL] [Abstract][Full Text] [Related]
15. STIM1 deficiency is linked to Alzheimer's disease and triggers cell death in SH-SY5Y cells by upregulation of L-type voltage-operated Ca Pascual-Caro C; Berrocal M; Lopez-Guerrero AM; Alvarez-Barrientos A; Pozo-Guisado E; Gutierrez-Merino C; Mata AM; Martin-Romero FJ J Mol Med (Berl); 2018 Oct; 96(10):1061-1079. PubMed ID: 30088035 [TBL] [Abstract][Full Text] [Related]
16. Lack of hepatic apoE does not influence early Aβ deposition: observations from a new APOE knock-in model. Huynh TV; Wang C; Tran AC; Tabor GT; Mahan TE; Francis CM; Finn MB; Spellman R; Manis M; Tanzi RE; Ulrich JD; Holtzman DM Mol Neurodegener; 2019 Oct; 14(1):37. PubMed ID: 31623648 [TBL] [Abstract][Full Text] [Related]
17. Neuron-specific apolipoprotein e4 proteolysis is associated with increased tau phosphorylation in brains of transgenic mice. Brecht WJ; Harris FM; Chang S; Tesseur I; Yu GQ; Xu Q; Dee Fish J; Wyss-Coray T; Buttini M; Mucke L; Mahley RW; Huang Y J Neurosci; 2004 Mar; 24(10):2527-34. PubMed ID: 15014128 [TBL] [Abstract][Full Text] [Related]
18. Generation of a set of isogenic, gene-edited iPSC lines homozygous for all main APOE variants and an APOE knock-out line. Schmid B; Prehn KR; Nimsanor N; Garcia BIA; Poulsen U; Jørring I; Rasmussen MA; Clausen C; Mau-Holzmann UA; Ramakrishna S; Muddashetty R; Steeg R; Bruce K; Mackintosh P; Ebneth A; Holst B; Cabrera-Socorro A Stem Cell Res; 2019 Jan; 34():101349. PubMed ID: 30660866 [TBL] [Abstract][Full Text] [Related]
19. Glia-specific APOE epigenetic changes in the Alzheimer's disease brain. Tulloch J; Leong L; Thomson Z; Chen S; Lee EG; Keene CD; Millard SP; Yu CE Brain Res; 2018 Nov; 1698():179-186. PubMed ID: 30081037 [TBL] [Abstract][Full Text] [Related]
20. Major decrease in the volume of the entorhinal cortex in patients with Alzheimer's disease carrying the apolipoprotein E epsilon4 allele. Juottonen K; Lehtovirta M; Helisalmi S; Riekkinen PJ; Soininen H J Neurol Neurosurg Psychiatry; 1998 Sep; 65(3):322-7. PubMed ID: 9728943 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]